EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jan. 26, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE), an emerging specialty pharmaceuticals company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, today filed its Form 10-Q for the third quarter of 2005 with the Securities and Exchange Commission (SEC). As a result of today’s filing, Savient now believes that it is in compliance with all listing requirements of The Nasdaq National Market.
